Cannabinoid receptor 1-labeled boutons in the sclerotic dentate gyrus of epileptic sea lions.
CB1
Hippocampus
Interneuron
Stereology
Temporal lobe epilepsy
Terminal
Journal
Epilepsy research
ISSN: 1872-6844
Titre abrégé: Epilepsy Res
Pays: Netherlands
ID NLM: 8703089
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
received:
27
12
2021
revised:
13
05
2022
accepted:
10
06
2022
pubmed:
21
6
2022
medline:
14
7
2022
entrez:
20
6
2022
Statut:
ppublish
Résumé
Pathology in the dentate gyrus, including sclerosis, is a hallmark of temporal lobe epilepsy, and reduced inhibition to dentate granule cells may contribute to epileptogenesis. The perisomatic-targeting axonal boutons of parvalbumin-expressing interneurons decrease in proportion with granule cells in temporal lobe epilepsy. In contrast, dendrite-targeting axonal boutons of somatostatin-expressing interneurons sprout exuberantly in temporal lobe epilepsy. A third major class of GABAergic interneurons expresses cannabinoid receptor type 1 (CB1) on their terminal boutons, but there is conflicting evidence as to whether these boutons are increased or decreased in temporal lobe epilepsy. Naturally occurring temporal lobe epilepsy in California sea lions, with unilateral or bilateral sclerosis, offers the benefit of neuroanatomy and neuropathology akin to humans, but with the advantage that the entirety of both hippocampi from control and epileptic brains can be studied. Stereological quantification in the dentate gyrus revealed that sclerotic hippocampi from epileptic sea lions had fewer CB1-labeled boutons than controls. However, the reduction in the number of granule cells was greater, resulting in increased CB1-labeled boutons per granule cell in sclerotic hippocampi at temporal levels. This suggests that although CB1-expressing boutons are decreased in sclerotic dentate gyri, surviving cells have enhanced innervation from these boutons in epileptic sea lions.
Identifiants
pubmed: 35724601
pii: S0920-1211(22)00116-4
doi: 10.1016/j.eplepsyres.2022.106965
pii:
doi:
Substances chimiques
Receptors, Cannabinoid
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
106965Subventions
Organisme : NIEHS NIH HHS
ID : R01 ES021960
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS039110
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS107290
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA041229
Pays : United States
Organisme : NIH HHS
ID : T35 OD010989
Pays : United States
Informations de copyright
Copyright © 2022 Elsevier B.V. All rights reserved.